GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (FRA:6QC) » Definitions » Shiller PE Ratio

TOWA Pharmaceutical Co (FRA:6QC) Shiller PE Ratio : 12.89 (As of Jun. 04, 2024)


View and export this data going back to 2021. Start your Free Trial

What is TOWA Pharmaceutical Co Shiller PE Ratio?

As of today (2024-06-04), TOWA Pharmaceutical Co's current share price is €17.40. TOWA Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was €1.35. TOWA Pharmaceutical Co's Shiller PE Ratio for today is 12.89.

The historical rank and industry rank for TOWA Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

FRA:6QC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 8.44   Med: 13.45   Max: 22.66
Current: 13.56

During the past years, TOWA Pharmaceutical Co's highest Shiller PE Ratio was 22.66. The lowest was 8.44. And the median was 13.45.

FRA:6QC's Shiller PE Ratio is ranked better than
77.43% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23.99 vs FRA:6QC: 13.56

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

TOWA Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.591. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €1.35 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


TOWA Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for TOWA Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Shiller PE Ratio Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.97 13.83 13.82 9.65 -

TOWA Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.65 8.64 13.56 11.03 -

Competitive Comparison of TOWA Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Shiller PE Ratio falls into.



TOWA Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

TOWA Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=17.40/1.35
=12.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, TOWA Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.591/106.8000*106.8000
=0.591

Current CPI (Dec. 2023) = 106.8000.

TOWA Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.118 95.700 0.132
201406 0.181 98.000 0.197
201409 0.395 98.500 0.428
201412 0.645 97.900 0.704
201503 0.333 97.900 0.363
201506 0.316 98.400 0.343
201509 0.258 98.500 0.280
201512 0.325 98.100 0.354
201603 0.204 97.900 0.223
201606 -0.189 98.100 -0.206
201609 0.211 98.000 0.230
201612 0.725 98.400 0.787
201703 0.120 98.100 0.131
201706 0.302 98.500 0.327
201709 0.327 98.800 0.353
201712 0.432 99.400 0.464
201803 -0.136 99.200 -0.146
201806 0.521 99.200 0.561
201809 0.375 99.900 0.401
201812 0.630 99.700 0.675
201903 0.452 99.700 0.484
201906 0.580 99.800 0.621
201909 0.524 100.100 0.559
201912 0.605 100.500 0.643
202003 0.558 100.300 0.594
202006 0.518 99.900 0.554
202009 0.497 99.900 0.531
202012 0.482 99.300 0.518
202103 0.653 99.900 0.698
202106 0.795 99.500 0.853
202109 0.603 100.100 0.643
202112 0.890 100.100 0.950
202203 0.139 101.100 0.147
202206 0.193 101.800 0.202
202209 0.189 103.100 0.196
202212 -0.101 104.100 -0.104
202303 0.031 104.400 0.032
202306 0.630 105.200 0.640
202309 0.284 106.200 0.286
202312 0.591 106.800 0.591

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


TOWA Pharmaceutical Co  (FRA:6QC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


TOWA Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (FRA:6QC) Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (FRA:6QC) Headlines

No Headlines